logo

HOME/FACULTY& STAFF/ PROFILE

Department of Chemical Sciences >
Dr. N. Shankaraiah >
Dr. N. Srinivas >
Dr. Y.V. Madhavi >
Dr. Priyanka Bajaj >

Faculty Profile : Dr. Srinivas Nanduri

Name: Dr. Srinivas Nanduri


Professor
nanduri.niperhyd@gov.in
+91 40 23074750 Extn- 2007
Google Scholar Citations


ADDRESS, ROOM NO,

Department of Chemical Sciences
Room. No. 15 & 16, NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA



QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

  1. PhD (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1991)
  2. M.Sc (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1988)
  3. B.Sc (Chemistry): Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (1986)



EXPERIENCE
  1. Professor, Department of Chemical Sciences at NIPER Hyderabad (Dec 2019 – Present)
  2. Dean, NIPER Hyderabad (March, 2020 to September, 2021)
  3. Associate Professor, Department of Chemistry at Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (Aug 2019- Dec 2019)
  4. Associate Professor, Department of Process Chemistry at NIPER Hyderabad (Sep 2013- July 2019)
  5. Director, Medicinal Chemistry department at Albany Molecular Research (India), Hyderabad (June 2012- June 2013)
  6. Research Director, Aurigene Discovery Technologies Ltd., Bangalore (Dec 2008- May 2012)
  7. Chief Scientific Manager, Biocon BMS Research Centre, Bangalore (March 2008- Nov 2008)
  8. Senior Director, Dr. Reddy’s Laboratories Ltd., Hyderabad, INDIA (Sep 1995- Feb 2008)
  9. Lecturer, Sri Sathya Sai Institute of Higher Learning, Prasanthinilayam, A.P. India (Jan 1992 – Aug 1995)


COURSES HANDLING(PHD/M.PHARM)

  1. PT-560 : Synthetic Aspects of Process Chemistry
  2. PT-630 : Synthetic Bulk Drug Technology
  3. LG-510 : General Laboratory Experience
  4. MC-650: Stereochemistry and Drug Action
  5. PT-710: Technologies for Green Chemistry
  6. NP-720: Natural Product-Based Drugs and Lead Molecules



PHD STUDENTS/MASTERS STUDENTS

Guided more than 50 M.S. (Pharm) / M. Tech (Pharm) students.
PhD: 5 (Guide) completed
10 ongoing



AWARDS / HONOURS

-



RESEARCH AREAS/INTEREST

  • Drug Discovery & Development in the areas of
  •        a. Anti-microbial
           b. Anti-cancer
           c. Neurodegenerative disorders
  • Process Optimization and Green Chemistry.
  • Natural products, Isolation and Characterization, total synthesis and semi-synthesis.


  • SPONSORED PROJECTS
    S.No Title of the Project Funding Organization Role Amount (In INR) Status
    1 Design, synthesis, and development of scalable route towards novel compounds based on the hybrid structure of Hymenialdisins and Paullones and a novel scaffold derived from Variolins Ministry of Earth Sciences Principal Investigator (PI) 45 Lakhs (2016-2019) Completed
    2 Synthesis and therapeutic evaluation of new LpxC inhibitors as potent anti- bacterial agents DST-SERB Principal Investigator (PI) 43 Lakhs (2017-2020) Completed
    3 Repurposing Oxiconazole: Alone and in combination with PUFA's as a broad spectrum antibacterial agents DBT Co-Principal Investigator (Co-PI) 40 Lakhs (2019-2022) In Progress
    4 Design, synthesis and biological evaluation of new GSK3β; inhibitors as promising therapeutic agents for treating Traumatic brain injury and consequent neuronal degenerative diseases ICMR Principal Investigator (PI) 50 Lakhs (2020-2023) In Progress
    5 Development of a scalable route for the manufacture of Prussian Blue insoluble of Pharmaceutical grade, an FDA approved decorporation drug LSRB Co-Principal Investigator (Co-PI) 49 Lakhs (2019-2022) In Progress


    PUBLICATIONS / BOOK CHAPTERS

    57 in peer reviewed journals
    Please Click here to see the full list.



    PATENTS

    54 filed (19 granted)
    Please Click here to see the full list.



    INVITED TALKS

    More than 30



    CONFERENCES / SEMINARS / WORKSHOPS ORGANIZED
    S.No Name of the Conference /Seminar / Workshop Year Role
    1 NIPER - PHARMA INDUSTRY MEET (SYNERGY - 2018) The Role of Academia in Strengthening the Indian Pharma 23rd August, 2018 Convener
    2 Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module III 13th -14th April, 2018 Convener
    3 Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module II 9th - 10th March, 2018 Convener
    4 Workshop on Drug Discovery & Development; Concept, Clinic & Commercialization (D3C3): Module I 16th - 17th February, 2018 Convener
    5 NIPER - Pharma Industry Meet (Role of Academia in Strengthening of Indian Pharma) 24th March 2017 Convener
    6 Conference on Drug Discovery & Development (Focus on Cancer & Diabetes) 16th & 17th March, 2017 Convener
    7 Conference on Innovations in Pharmaceutical Technologies & Workshop on GLP/GMP compliance 24th& 25th January 2017 Convener
    8 Conference on "Quality Management in Bulk Drug and Formulation Manufacturing" 12th& 13th Aug. 2016 Convener
    9 One day workshop on "Emerging Trends In Pharmaceutical Sciences" 9th July 2016 Convener
    10 Conference on Fostering Innovation in Pharmaceutical and IPR Management 21st -22nd March 2016 Convener
    11 Conference on Drug Discovery & Development (Global Scenario – Indian perspective) 20th -21st November 2015 Convener
    12 National Conference on Innovative Processes for Bulk Drugs (IPBD) 26th - 27th March 2015 Convener
    13 International Conference on Drugs for the Future: Infectious Diseases (DFID) 27th -28th March 2014 Convener


    ADDITIONAL RESPONSIBILITIES

    1. Coordinator, National Center for R & D Bulk Drugs Development
    2. Coordinator, Avishkaran, BioNEST Incubation Center at NIPER-Hyderabad
    3. Dean, NIPER-Hyderabad (March 2020- Aug 2021)
    4. Head of the Department, Department of Chemical Sciences, NIPER-Hyderabad (Aug 2020- Aug 2021)
    5. Convener, NIPER-JEE 2020 (Medical Devices)
    6. Head of the Department, Department of Process Chemistry, NIPER-Hyderabad (2014-2019)
    7. Placement Officer, NIPER-Hyderabad (2013-2018)



    ANY OTHER INFORMATION

    Developed 4 research labs for the chemical synthesis